BSc (Hons), MSc, MBPsS
Clinical Trials Manager
SuMMiT-D, PACE Oxford
PACE is a randomised controlled trial that aims to evaluate whether using a CRP point of care test (POCT) results in better targeting of antibiotic treatment than usual care informed by NICE and GOLD guidelines. The primary outcomes are the overall consumption of antibiotics for COPD and patient-rated clinical recovery from their acute exacerbations, with the aim being to reduce overall antibiotic use without compromising patient recovery.
SuMMiT-D is a six-year NIHR funded programme to develop a digital-health messaging tool to support people with type 2 diabetes in best use of medicines and to test it as part of a wider system of support in clinical trials.
I have previously worked on:
INVICTUS: A large scale Phase II trial aiming to determine the safety and efficacy of a new flu vaccine in combination with the seasonal flu vaccine in adults 65 years and older.
RIVET: A pilot study aiming to examine the feasibility and acceptability of the baseline and follow-up processes of INVICTUS.
ATAFUTI: A phase III trial investigating alternative treatments to antibiotics in adult women with suspected UTI.
ALIC4E-Oxford: An open adaptive-platform randomised trial examining the use of antivirals for flu-like illness as a clinical and cost effective treatment (compared to current best practice).
TOAST: investigating treatment options without antibiotics for sore throat.
Prior to my current position:
Assistant project manager at the Diabetes Trials Unit (OCDEM): working on a multinational secondary care trial (EXSCEL).
Research assistant at the Health Experiences Research Group (HERG): working on projects related to
young people's experiences with primary care,
patients' experiences with chronic kidney disease,
young people's experiences with cancer,
SES and diabetes management and,
patients' experiences with shoulder and knee replacement surgery.
Bates J. et al, (2017), Trials, 18, 442 - 442